share_log

Scotiabank Downgrades Syndax Pharmaceuticals to Sector Perform, Lowers Price Target to $23

Benzinga ·  Jan 31 09:58

Scotiabank analyst George Farmer downgrades Syndax Pharmaceuticals (NASDAQ:SNDX) from Sector Outperform to Sector Perform and lowers the price target from $36 to $23.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment